Mirae Asset Global ETFs Holdings
GALT icon

Mirae Asset Global ETFs Holdings’s Galectin Therapeutics GALT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Buy
+22,066
New +$57.2K ﹤0.01% 2811
2025
Q3 		– Sell
-374
Closed -$789 – 3116
2025
Q2 		$789 Sell
374
-4,014
-91% -$6K ﹤0.01% 2993
2025
Q1 		$5.35K Sell
4,388
-7,317
-63% -$10.3K ﹤0.01% 3037
2024
Q4 		$15.1K Buy
11,705
+532
+5% +$1.27K ﹤0.01% 3017
2024
Q3 		$30.7K Buy
+11,173
New +$27.4K ﹤0.01% 2987

Other funds holding GALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Mirae Asset Global ETFs Holdings's GALT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Galectin Therapeutics (GALT) in Q2 2026: 22,066 shares worth $102K. The stake represents ﹤0.01% of the portfolio and ranks #2811 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in GALT as recently as Q2 2025.

Mirae Asset Global ETFs Holdings first reported a position in GALT in Q3 2024 and has held it in 5 quarters since. 98 funds tracked by Wall St. Rank hold GALT as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 22,066 shares of Galectin Therapeutics worth $102K as of Q2 2026.
  • Galectin Therapeutics was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Galectin Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2811 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Galectin Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • 98 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.